Thalidomide in combination with oral daily cyclophosphamide in patients with pretreated hormone refractory prostate cancer: A phase I clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thalidomide in combination with oral daily cyclophosphamide in patients with pretreated hormone refractory prostate cancer: A phase I clinical trial

Published:2007-03 Issue:3 Volume:6 Page:313-317
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Di Lorenzo Giuseppe,Autorino Riccardo,De Laurentiis Michele,Forestieri Valeria,Romano Carmela,Prudente Antonella,Giugliano Francesco,Imbimbo Ciro,Mirone Vincenzo,De Placido Sabino

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/cbt.6.3.3664

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metronomic Chemotherapy for Advanced Prostate Cancer: A Literature Review;Journal of Clinical Medicine;2022-05-15

2. Clinical trials on combination of repurposed drugs and anticancer therapies;Drug Repurposing in Cancer Therapy;2020

3. Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer;Future Oncology;2019-04

4. Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience;Journal of Oncology;2019-03-20

5. Efficacy of metronomic oral cyclophosphamide with low dose dexamethasone and celecoxib in metastatic castration-resistant prostate cancer;Asia-Pacific Journal of Clinical Oncology;2016-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP